Skip to content
OpenCapital
Get started

Achieve Life Sciences ACHV Cash ratio

Cash ratio at other companies

Pfizer logo
PfizerPFE
0.1×0.0×
Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
6.6×-2.2×
Philip Morris International logo
Philip Morris InternationalPM
0.2×0.0×

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0—
Free cash flow-$12.4M—

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Calculated from Achieve Life Sciences’s reported figures.

cash and equivalents/total current liabilities=2.4×

Based on the most recent quarter.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's cash ratio?
Achieve Life Sciences (ACHV) reported cash ratio of 2.4× in Q1 2026.
How has Achieve Life Sciences's cash ratio changed year-over-year?
Achieve Life Sciences's cash ratio increased by 30.0% year-over-year, from 1.8× to 2.4×.
What is the long-term trend for Achieve Life Sciences's cash ratio?
Over 5 years (2020 to 2025), Achieve Life Sciences's cash ratio has grown at a -28.4% compound annual growth rate (CAGR), from 12.2× to 2.3×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.